Justus Apffelstaedt

4.9k total citations · 2 hit papers
44 papers, 2.2k citations indexed

About

Justus Apffelstaedt is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Justus Apffelstaedt has authored 44 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 14 papers in Genetics and 11 papers in Cancer Research. Recurrent topics in Justus Apffelstaedt's work include Global Cancer Incidence and Screening (17 papers), Breast Cancer Treatment Studies (11 papers) and Bone health and treatments (10 papers). Justus Apffelstaedt is often cited by papers focused on Global Cancer Incidence and Screening (17 papers), Breast Cancer Treatment Studies (11 papers) and Bone health and treatments (10 papers). Justus Apffelstaedt collaborates with scholars based in South Africa, United States and United Kingdom. Justus Apffelstaedt's co-authors include John R. Mackey, Anthony Howell, John J. Seaman, Andrew R. Belch, Dirk J. Reitsma, Mary Kaminski, Robert E. Coleman, Lee S. Rosen, David Gordon and Mohamad A. Hussein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Justus Apffelstaedt

43 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

2002 676 citations Lee S. Rosen, David Gordon et al. PubMed profile →
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

2003 657 citations Lee S. Rosen, David Gordon et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Justus Apffelstaedt South Africa	15	1.7k	630	561	553	473	44	2.2k
Lester Porter United States	8	1.8k 1.1×	637 1.0×	363 0.6×	542 1.0×	451 1.0×	9	2.1k
Piotr Milecki Poland	22	1.7k 1.0×	853 1.4×	430 0.8×	1.3k 2.3×	351 0.7×	99	2.6k
George Bozas Greece	16	1.1k 0.6×	105 0.2×	262 0.5×	272 0.5×	652 1.4×	47	1.7k
N. O’Rourke United Kingdom	16	651 0.4×	351 0.6×	404 0.7×	985 1.8×	384 0.8×	44	1.8k
Christiane Franzius Germany	23	292 0.2×	811 1.3×	584 1.0×	1.1k 1.9×	55 0.1×	58	2.2k
Helen Marshall United Kingdom	20	2.5k 1.5×	376 0.6×	1.7k 3.0×	646 1.2×	124 0.3×	39	2.9k
P. Garaud France	19	735 0.4×	183 0.3×	1.9k 3.3×	591 1.1×	64 0.1×	49	2.7k
Eugenio Salizzoni Italy	18	327 0.2×	385 0.6×	191 0.3×	500 0.9×	73 0.2×	27	1.4k
G P Canellos United States	23	1.2k 0.7×	390 0.6×	222 0.4×	728 1.3×	16 0.0×	33	2.8k
Karin S. Kapp Austria	24	737 0.4×	265 0.4×	475 0.8×	458 0.8×	17 0.0×	69	1.9k

Countries citing papers authored by Justus Apffelstaedt

Since Specialization

Citations

This map shows the geographic impact of Justus Apffelstaedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justus Apffelstaedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justus Apffelstaedt more than expected).

Fields of papers citing papers by Justus Apffelstaedt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justus Apffelstaedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justus Apffelstaedt. The network helps show where Justus Apffelstaedt may publish in the future.

Co-authorship network of co-authors of Justus Apffelstaedt

This figure shows the co-authorship network connecting the top 25 collaborators of Justus Apffelstaedt. A scholar is included among the top collaborators of Justus Apffelstaedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justus Apffelstaedt. Justus Apffelstaedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peeters, Armand V., et al.. (2020). CYP19A1 rs10046 Pharmacogenetics in Postmenopausal Breast Cancer Patients Treated with Aromatase Inhibitors: One-year Follow-up. Current Pharmaceutical Design. 26(46). 6007–6012. 5 indexed citations

Kotze, Maritha J., et al.. (2016). Impact of MammaPrint on Clinical Decision-Making in South African Patients with Early-Stage Breast Cancer. The Breast Journal. 22(4). 442–446. 11 indexed citations

Brundyn, Karen, et al.. (2015). Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer. The Breast. 24(2). 137–142. 6 indexed citations

Apffelstaedt, Justus, et al.. (2013). Implementation of a breast cancer genetic service in South Africa – lessons learned. South African Medical Journal. 103(8). 529–529. 21 indexed citations

Rensburg, Susan J. van, et al.. (2012). Influence of Genetic Factors on the Development of Breast Cancer in the Older Woman. Current Aging Science. 5(2). 140–147. 6 indexed citations

Apffelstaedt, Justus, et al.. (2012). 7-year follow up of intra-operative radiotherapy for early breast cancer in a developing country. The Breast. 21(3). 326–329. 9 indexed citations

Apffelstaedt, Justus, et al.. (2011). Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment. Breast Cancer Research and Treatment. 129(1). 99–106. 3 indexed citations

Apffelstaedt, Justus, et al.. (2010). Surgical Mammography Reporting in a Limited Resource Environment. World Journal of Surgery. 34(11). 2530–2536. 3 indexed citations

Poznak, Catherine Van, R.A. Hannon, John R. Mackey, et al.. (2010). Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial. Journal of Clinical Oncology. 28(6). 967–975. 164 indexed citations

10.

Apffelstaedt, Justus, et al.. (2008). Performance data of screening mammography at a dedicated breast health centre.. PubMed. 98(12). 950–3. 6 indexed citations

11.

Apffelstaedt, Justus, et al.. (2008). Breast cancer in emerging countries: The status of breast care in South Africa. European Journal of Cancer Supplements. 6(7). 167–167. 1 indexed citations

12.

Apffelstaedt, Justus, et al.. (2008). Counseling for male BRCA mutation carriers – a review. The Breast. 17(5). 441–450. 52 indexed citations

13.

Rosen, Lee S., David Gordon, Mary Kaminski, et al.. (2003). Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma. Cancer. 98(8). 1735–1744. 657 indexed citations breakdown →

14.

Apffelstaedt, Justus. (2003). Locally Advanced Breast Cancer inDeveloping Countries: The Place of Surgery. World Journal of Surgery. 27(8). 917–920. 7 indexed citations

15.

Sandelin, Kerstin, et al.. (2002). Breast Surgery International — Breast Cancer in Developing Countries. Scandinavian Journal of Surgery. 91(3). 222–226. 23 indexed citations

16.

Coleman, RE, Justus Apffelstaedt, Domonick K Gordon, et al.. (2001). Zometa® is effective and well tolerated in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy. European Journal of Cancer. 37. S152–S152. 4 indexed citations

17.

Voss, Miranda, J Schneider, & Justus Apffelstaedt. (1999). Axillary lymph node involvement in stage III breast cancer: Treatment implications. Journal of Surgical Oncology. 71(3). 162–166. 5 indexed citations

18.

Apffelstaedt, Justus, et al.. (1997). Malignant pericardial effusion in breast cancer: Terminal event or treatable complication?. Journal of Surgical Oncology. 64(4). 308–311. 13 indexed citations

19.

Apffelstaedt, Justus, Deborah L. Driscoll, James E. Spellman, et al.. (1996). Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Annals of Surgical Oncology. 3(3). 304–309. 83 indexed citations

20.

Apffelstaedt, Justus, et al.. (1995). Various types of hemipelvectomy for soft tissue sarcomas: complications, survival and prognostic factors. Surgical Oncology. 4(4). 217–222. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact